Carboplatin/paclitaxel

Carboplatin/gemcitabine

Carboplatin/pemetrexed

Carboplatin/paclitaxel/bevacizumab

HTN

37.7%

37.1%

56.0%

25.0%

DM

8.5%

17.1%

28.0%

3.6%

COPD

23.6%

22.9%

32.0%

17.9%

CAD

11.3%

17.1%

16.0%

3.6%

Renal Disease

2.8%

2.9%

0.0%

0.0%

Liver Disease

0.9%

0.0%

12.0%

0.0%